Why Are Cannabis Stocks Gaining Attention Right Now
Cannabis companies attract renewed attention as reclassification discussions progress and upcoming regulatory proceedings shape expectations across the evolving industry.
Robinhood Is Opening the Door to U.S. Cannabis With Reform On the Horizon
Trulieve, Curaleaf, and Green Thumb Industries showed up on the app this week as the federal government inches toward reclassifying recreational marijuana.
Cannabis, Wellness And Beverages: Three Names To Watch
Tilray, Canopy Growth and Cronos are three US-listed names at the intersection of cannabis, wellness and beverages.
Cannabis Stocks On NASDAQ Markets: A Guide For U.S.
Discover how U.S.-traded cannabis stocks work, what defines the cannabis universe on NASDAQ and OTC markets, and what U.S. investors typically consider.
Cannabis MSO Curaleaf prepares for uplisting on US stock exchanges
Curaleaf will execute a 1-for-3 reverse stock split positioning it to uplist to a U.S. stock exchange cannabis rescheduling creates an opening to do so.
CBD Stocks Creating Opportunities – Established (BCCI), (STG), (WEED), (ACRGF), (RLTR), (CBMJ), and Newcomer (VAPR) Lead the Charge
You would have to be living in isolation to have not picked up on the hottest marijuana derivative consumable and therapeutic center isolate CBD. CBD “Cannabidiol” is the non-psychoactive full spectrum derivative of the hemp and marijuana plant largely credited for the majority of the medical beneficial attributes associated with marijuana.
Trulieve set to become first cannabis company listed on the NYSE
Trulieve Cannabis Co., Florida’s largest marijuana provider and one of the biggest in the nation, has been approved for listing on the New York Stock Exchange (NYSE). Voting shares are expected to …
Trulieve Cannabis to Debut on NYSE After Restructuring, U.S. Marijuana Reclassification
Trulieve Cannabis received regulatory approval to list its shares on the New York Stock Exchange, becoming the first cannabis company cleared to trade on a major U.S. stock exchange.
Cannabis Stocks Are Climbing — And the Biggest Catalyst Hasn’t Even Arrived Yet
Cannabis stocks remain in focus as a key federal hearing approaches, with Green Thumb Industries and Curaleaf among closely watched sector participants.
Why Are NYSE Composite Cannabis Penny Stocks Swinging on Rescheduling?
Cannabis penny stock activity remains volatile as rescheduling discussions, regulatory hearings, and industry developments continue drawing attention across the NYSE Composite.
Auxly Cannabis is still undervalued, this analyst says
Haywood analyst Neal Gilmer maintained a “Buy” rating and $0.25 target on Auxly Cannabis Group (Auxly Cannabis Group Stock Quote, Chart, News, Analysts, Financials TSX:XLY) in a May 14 report after …
Buy this cannabis stock for a double, analyst says
Haywood analyst Neal Gilmer maintained a “Buy” rating and $3.25 target on Organigram Holdings (Organigram Global Stock Quote, Chart, News, Analysts, Financials TSX:OGI) in a M …
Is Canopy Growth Stock Finally Setting Up for a Real Turnaround?
Canopy Growth (NASDAQ: CGC) has made considerable efforts to turn itself around. Over the past few years, the Canada-based cannabis company has significantly reduced its outstandi …
Canopy Growth Is One of the Market’s Most Polarizing Stocks: 3 Scenarios for the Next 12 Months
After years of heavy losses and repeated restructurings, Canopy Growth is showing early signs of stabilization.
Cannabis Revenue Decline Pressures Organigram Earnings Despite Germany Expansion (OGI)
Organigram reported weaker second-quarter revenue and profitability as vape and infused pre-roll sales slowed, while the company positioned its Sanity Group acquisition as a major international growth …
Recent Comments